Slight advantages of nimotuzumab versus cetuximab plus concurrent chemoradiotherapy in locally advanced esophageal squamous cell carcinoma

Jing, W; Yan, WW; Liu, YG; Li, J; Yu, JM; Zhu, H

Zhu, H (reprint author), Shandong Univ, Dept Radiat Oncol, Shandong Canc Hosp, Rd Jiyan 440, Jinan 250117, Shandong, Peoples R China.

CANCER BIOLOGY & THERAPY, 2019; 20 (8): 1121

Abstract

This study aimed to compare the efficacy of nimotuzumab (Nimo) versus cetuximab (C225) plus concurrent chemoradiotherapy (CCRT) in locally advanced es......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索